🇺🇸 FDA
Pipeline program

Prostavue

IASON FC303

Phase 3 small_molecule active

Quick answer

Prostavue for Prostate cancer is a Phase 3 program (small_molecule) at Curium Romania S.R.L. with 1 ClinicalTrials.gov record(s).

Program details

Company
Curium Romania S.R.L.
Indication
Prostate cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials